Torskal SAS, a French oncology innovator developing non-ionizing plasmonic PTT for cancers, has partnered with Houston-based SaniMed as its fundraising and strategic business consultant for US and international markets. SaniMed’s expertise in life science investments and commercialization will drive Torskal’s expansion and clinical development. The alliance accelerates breakthrough treatment advancements.

SaniMed Science Group offers U.S. high school and college students unique internships in medical innovation, business, and finance. Interns gain real-world experience, expert mentorship, and global exposure while enhancing leadership, communication, and professional skills—preparing them for competitive careers in the healthcare and tech-driven business sectors.

SaniMed Science Group launches a 30-second TV ad in Houston, highlighting its role in empowering MedTech innovation and startup growth.

In this interview, Jim Wu, founder of SaniMed, shares insights on medical device investment, clinical research, and strategic partnerships.

WMIC 2024 SaniMed and TomoWave are thrilled to announce our participation at WMIC 2024! 🌟 Join us at booth "309" and explore our latest...